Adverse Events and Oncotargeted Kinase Inhibitors

Adverse Events and Oncotargeted Kinase Inhibitors

by Giuseppe Tridente

NOOK Book(eBook)

$170.49 $200.00 Save 15% Current price is $170.49, Original price is $200. You Save 15%.
View All Available Formats & Editions

Available on Compatible NOOK Devices and the free NOOK Apps.
WANT A NOOK?  Explore Now

Product Details

ISBN-13: 9780128094457
Publisher: Elsevier Science
Publication date: 05/08/2017
Sold by: Barnes & Noble
Format: NOOK Book
Pages: 736
File size: 8 MB

About the Author

Professor Emeritus of Immunology and Pathology

School of Medicine and Surgery

Coordinator of the Teachers’ Committee for the Master in Translational Biomedicine

Universita degli Studi di Verona, Italy

Table of Contents

Part I: General Aspects 1. Introduction 2. Protein and Lipid Kinases 3. Kinase Inhibitors 4. Adverse Events

Part II: Oncotargeted Kinase Inhibitors 5. Imatinib 6. Gefitinib 7. Erlotinib 8. Sorafenib 9. Sunitinib 10. Dasatinib 11. Lapatinib 12. Nilotinib 13. Pazopanib 14. Vandetanib 15. Vemurafenib 16. Crizotinib 17. Ruxolitinib 18. Axitinib 19. Bosutinib 20. Regorafenib 21. Cabozantinib 22. Ponatinib 23. Dabrafenib 24. Trametinib 25. Adatinib 26. Idelalisib 27. Ibrutinib

Part III: Overview 28. Kinase Inhibitors as Adverse Event Inducers 29. Kinase Inhibitors as Drug Class Events 30. Conclusion and Perspectives

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews